Sanofi India has signed a memorandum of understanding with National Institute of Pharmaceutical Education and Research (NIPER) Kolkata – an autonomous body set up under the Department of Pharmaceuticals, Government of India – to promote academic excellence and research. Two sides will be collaborate in the areas of pharmaceuticals and consumer healthcare products to cater to the current and future needs of the pharmaceutical industry.
Through this initiative, Sanofi India will participate in revision or formulation of curriculum for a post-graduate (MS) & Ph D programme, and undertake collaborative research activities in identified areas.
“The era of academic-industry collaboration to address the mammoth task of capacity building to meet our healthcare challenges has well and truly begun. Only a well-equipped and trained workforce can face future challenges and cater to the vast healthcare needs of the nation. We are proud to associate with NIPER Kolkata in this collaborative exercise to hone the students’ skill-sets, and empower them for future, based on our practical knowledge and research experience,” said Dr Shailesh Ayyangar, managing director, Sanofi India Ltd.
As per the MoU, the key deliverables for Sanofi India will be to assist NIPER Kolkata foster students with updated knowledge, and who are ready for the pharmaceutical industry. The collaboration will focus in the areas of NIPER Kolkata’s expertise such as novel small molecules for anti-diabetics & drug resistant tuberculosis (TB), API by synthetic biology & cell factory, phyto-pharmaceuticals, etc.